Anika Therapeutics Inc. (ANIK) vs Emergent Biosolutions Inc. (EBS)
- Anika Therapeutics Inc. ANIK 19.98 −3.43%
- Emergent Biosolutions Inc. EBS 6.38 −11.14%
Anika Therapeutics Inc. and Emergent Biosolutions Inc. are both Drug Manufacturers Specialty & Generic companies. Emergent Biosolutions Inc. is the larger, with a market value of $368.1M against $276.9M — 1.3× the size. Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −9.56%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −23.0%) and the higher return on invested capital (−3.24% vs −5.27%). Across the 21 metrics below, Anika Therapeutics Inc. leads on 11 and Emergent Biosolutions Inc. on 10.
Valuation
Profitability
| Metric | ANIK | EBS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 62.16% | 55.87% | 53.94% |
| Operating margin | (4.24%) | (8.57%) | 0.00% |
| Net margin | (3.14%) | (22.96%) | 0.00% |
| Free cash flow margin | 0.47% | 11.18% | 0.00% |
| Return on equity | (2.66%) | (40.29%) | (0.40%) |
| Return on assets | (2.04%) | (13.95%) | (3.32%) |
| Return on invested capital | (3.24%) | (5.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack